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The Key Events Dose-Response Framework (KEDRF) is an analytical approach that facilitates the use of currently available
data to gain insight regarding dose-response relationships. The use of the KEDRF also helps identify critical knowledge
gaps that once ﬁlled, will reduce reliance on assumptions. The present study considers how the KEDRF might be applied
to pathogenic microorganisms, using fetal listeriosis resulting from maternal ingestion of food contaminated with L. mono-
cytogenes as an initial example. Major biological events along the pathway between food ingestion and the endpoint of
concern are systematically considered with regard to dose (i.e., number of organisms), pathogen factors (e.g., virulence),
and protective host mechanisms (e.g., immune response or other homeostatic mechanisms). It is concluded that the KEDRF
provides a useful structure for systematically evaluating the complex array of host and pathogen factors that inﬂuence the
dose-response relationship. In particular, the KEDRF supports efforts to specify and quantify the sources of variability, a
prerequisite to strengthening the scientiﬁc basis for food safety decision making.
Keywords dose-response, uncertainty factors, homeostatic mechanisms, thresholds, Listeria monocytogenes
INTRODUCTION
Major challenges in risk analysis for foodborne infectious
diseases include determining relationships between low level
exposuretopathogenicmicroorganismsandlikelypublichealth
outcomes, and translating those relationships into practical con-
trols that protect public health. This paper considers these chal-
lenges as part of a broader ILSI Research Foundation (ILSI RF)
effort to examine approaches to dose-response assessment for a
variety of bioactive agents including allergens, nutrients, toxic
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chemicals, and pathogenic microorganisms. For each category
ofagent,theILSIRFeffortappliedamode-of-actionbasedana-
lyticalframework,referredtoastheKeyEventsDose-Response
Framework (KEDRF) (Julien et al., 2009). After an overview of
current approaches to dose-response assessment for pathogenic
microorganisms, this paper discusses how KEDRF might be
applied to pathogens, using Listeria monocytogenes and fetal
listeriosis as an initial example.
OVERVIEW OF CURRENT APPROACHES AND
PRACTICE
“Infectious Dose” or “Minimum Infectious Dose” is a con-
cept traditionally used to describe in quantitative terms the abil-
ity of a pathogenic microorganism to cause illness and disease
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(FAO/WHO, 2003). This concept presumes that all infectious
agents have a particular dose level, a threshold dose, below
which the organism is not expected to cause disease. This pre-
sumption is based on data from various experimental studies,
with human subjects and animal models, which have identiﬁed
such dose levels. These studies are the microbiological equiva-
lentofsafetyassessmentsconductedforacutelytoxicchemicals.
Thus, the “minimum infectious dose” is conceptually similar to
the “no observed adverse effect level” (NOAEL) in toxicology.
Typically, however, studies used to identify a minimum infec-
tiousdosehavebeenlimitedinsamplesizeandthusconstrained
in their sensitivity to detect infrequent effects.
After a series of outbreaks of foodborne disease associated
with the consumption of low levels of pathogenic bacteria, the
minimum infectious dose or “threshold” presumption has been
increasingly replaced with a risk-based approach that takes into
account mechanistic considerations and, in particular, the prob-
abilistic nature of the infectious disease process (Haas, 1983;
FAO/WHO, 2003). This risk-based approach recognizes the
three major categories of foodborne pathogens—toxigenic, tox-
icoinfectious,andinvasive—whichdifferintheirgeneralunder-
lying mechanisms of pathogenesis. Table A-1 in the Appendix
describes these three categories, which are outlined very brieﬂy
here.
For toxigenic pathogens, which release a toxin into food
products prior to food ingestion, the dose-response relationship
isgenerallyassumedtohaveathresholdorminimumtoxicdose.
Thus, dose-response assessments for toxigenic pathogens adopt
assumptions similar to those for noncarcinogenic toxicants. On
the other hand, for toxicoinfectious and invasive pathogens,
the widely accepted underlying assumption is that there is no
biological threshold. In these cases, the ingestion of a single
bacterium is assumed to have some potential, albeit generally
very small, to cause infection1 and illness.
Accordingly, widely accepted mathematical dose-response
models for toxicoinfectious and invasive pathogens are based
on two fundamental assumptions (FAO/WHO 2003):
• Single hit assumption, i.e., the probability that any given mi-
croorganism will survive a number of barriers to establish
infection is non-zero.
• Independent action assumption, i.e., the probability that any
given organism will cause infection is independent of the
number ingested. Thus, the chance that a given bacterium
will cause an infection is not affected by dose, but the chance
that infection will occur increases directly with the number of
bacteria i.e., increases with dose.
There is substantial indirect evidence to support these two
assumptions (Meynell and Stocker, 1957; Moxon and Murphy,
1978; Rubin, 1987). There is limited knowledge, however, re-
1Infection is usually deﬁned as a condition in which a pathogen can actively multiply
in the body of the host. Infection may or may not be accompanied by clinical signs of
illness in the host (i.e., there may be symptomatic or asymptomatic infection).
garding the underlying biology and the variability of interaction
between pathogens and their hosts; this limits the possibility to
generalize from experimental datasets. For example, a recent
study on infection of insect larvae with baculoviruses, while
conﬁrming these hypotheses for several pathogen-host combi-
nations on the simple assumption of constant interaction, also
showed the need to incorporate variability into the predictive
models for other pathogen-host pairs (Zwart et al., 2009). An
examination of speciﬁc sources and the extent of variability
across these host-pathogen combinations would be needed in
order to reﬁne the predictive model.
Thus, at a minimum, current risk assessment approaches re-
quire the following information to estimate the probability of
infection and illness for an individual host or for a population:
• Mechanistic category of the pathogen
• Speciﬁc nature of the pathogen (i.e., virulence factors, gene
expression, stress response system, etc.)
• Dose (i.e., number of organisms ingested) over the deﬁned
period of time.
In addition, several other factors may substantially inﬂu-
ence the dose-response relationship and thus may need to be
considered. These include the susceptibility of the exposed per-
son or population, matrix effects associated with the food in
which the pathogen is suspended, and the particular strain of
the pathogenic microorganism. There can be substantial strain-
to-strain variability within a species or serotype, making it dif-
ﬁcult to collect the basic data needed to generate a single dose-
response curve for that pathogen (FDA/FSIS, 2003).
Data used to assess dose-response for pathogenic microor-
ganisms generally come from one of three types of studies—
outbreak, human volunteer, or experimental animal model stud-
ies. Each type of study has strengths and limitations. All three
approacheshavesubstantialuncertaintyduetotheinherentvari-
abilityinthepathogen,thehost,andthefoodvehicle.Ingeneral,
it is difﬁcult to collect data on the concentration of pathogen to
which a person was exposed and also difﬁcult to collect relevant
data on response.
For example, in most outbreak investigations the ingested
dose itself must be modeled because the pathogen may multiply
or die in the remaining contaminated food between the time
of ingestion and the collection of samples following onset of
symptoms (FAO/WHO, 2002; FAO/WHO, 2004; Teunis et al.,
2004, 2008). Typically, dose information is simply not avail-
able, and the variability among doses consumed by individuals
is almost never known. An exception may be the limited cases
where the food involved neither supports pathogen growth nor
causes rapid die-off. In such cases an analysis of food sam-
ples and epidemiological investigations can provide reasonably
accurate estimates of pathogen levels and the amount of food
consumed.2
2For example, the 1994 outbreak of Escherichia coli O157:H7 associated with dry,
fermented pork and beef salami (a product in which this pathogen can survive, but not720 R. L. BUCHANAN ET AL.
Another limitation with outbreak studies is the fact that the
speciﬁc nature/genetic makeup of the organism can change be-
tween the time of ingestion and the collection of food samples,
makingtheevaluationoftheinitialcausativeorganismproblem-
atic. Also, except in cases where the infection is associated with
a very speciﬁc illness (e.g., hemolytic uremic syndrome associ-
ated with E. coli O157:H7), an outbreak caused by a very low
dose (e.g., where less than 5% of those ingesting the pathogen
become ill) is unlikely to be detected due to the statistical dif-
ﬁculty in identifying cases. In the infrequent situation where
extensive data exist on likely exposure of a population to a
particular foodborne pathogen for a speciﬁc ready-to-eat food,
annual disease statistics in combination with the single parame-
terexponential model have been usedtogenerate dose-response
curves (Buchanan et al., 1997).
Humanvolunteerstudieshavetheadvantageofaknowndose
level and known agent. But inthis case, itisnecessary toextrap-
olate to account for potential differences between the test pop-
ulation and the exposed population, which for many infectious
pathogens include individuals with immune systems weakened
by age, immunosuppression, cytotoxic drugs, or pre-existing
disease. Volunteer studies cannot be done with individuals from
such susceptible populations because of the possibility of seri-
ous or fatal infections.
Enhanced investigation of outbreaks is one means of ac-
quiring information that is representative of foodborne disease
in the typical population, which includes individuals of vary-
ing immune-status. In an enhanced outbreak investigation, the
number of people who consumed a given food, the number who
becameill,thehealthstatusofthosewhobecameill,thenumber
of pathogens consumed (if available), and the properties of the
relevant pathogen strain are determined. Typically, information
fromoneoutbreakinvestigationprovidesasingledatapointona
population dose-response curve (the probability of illness given
a particular dose). An accumulation of outbreak data sets is
needed to establish the position of the dose response curve, and
a range of doses is needed to determine the shape of the curve.
A risk assessment conducted for Salmonella spp. (FAO/WHO,
2002) is a good example of the types of data needed; however,
such data sets are rarely available.
When human data are not available, animal models may be
used to establish the shape and position of the dose response
curve. With animal model studies, the mechanism of infection
and resulting illness should be shown to be the same as in
humans; otherwise, extrapolation is needed to account for the
inter-species differences. Such inter-species differences can be
substantial.Forexample,atthetimeofarecentFDA-USDArisk
assessment for L. monocytogenes, the only studies with sufﬁ-
cient data to obtain a dose-response curve for risk of stillbirth
from maternal exposure during gestation were mouse studies
(FDA/FSIS, 2003). The mouse fetus is susceptible to L. mono-
grow, for extended storage periods) provided clear evidence of the ability of low levels of
this organism to cause a signiﬁcant rate of disease (Getty et al., 2007).
cytogenes only under certain conditions (Abram et al., 2003;
Sahaghian et al., 2009, Lammerding et al., 1992; Klink and
Runkiki, 1995; Ito et al., 2004), and the mouse dose-response
curve differs from humans due to differences in the E-cadherin
receptor, the enterocyte cell surface receptor required for up-
take of the pathogen from the intestine (Lecuit, 1999). More
recently, oral route dose-response data for L. monocytogenes
have been collected in the pregnant guinea pig and pregnant
non-human primate. In these species the E-cadherin receptor
is the same as in the human and oral exposure results in still-
birth (Smith et al., 2003; Williams et al., 2007; Smith et al.,
2008).
Regardlessofthedatasource—outbreakdata,volunteerstud-
ies, or animal models—current approaches to dose-response
assessment for pathogenic microorganisms generally require a
number of extrapolations and assumptions. In addition to the
major extrapolations for species differences and the differences
in susceptibility among humans discussed above, other assump-
tions are typically adopted, including i) each episode of illness
is acute though the associated exposure event may be cumu-
lative for 1–2 days; ii) each exposure/dose is a separate inde-
pendent event; and iii) no immunity exists. Also, assumptions
regarding the distribution of pathogens in food products are
usually made.
Another very critical extrapolation, which in large part
prompted the present study, involves extrapolation from high
dose to the low doses typically relevant for public health. In
volunteer and in animal model studies, the number of subjects
is almost always too small to measure probabilities of infec-
tion at very low doses. Thus, administered doses are typically
much higher than the dose levels of practical concern. And
as already noted, it is very difﬁcult to detect outbreaks from
ingestion of low-dose levels. Because regulations are gener-
ally based on areas of the dose-response curve below actual
data points, assumptions and extrapolations must be made in
order to generate a full dose-response curve that includes rele-
vant dose levels. For toxicoinfectious and invasive pathogens,
the single hit and independent action assumptions underlie the
widely accepted mathematical modeling approaches for pre-
dicting the low end of the dose-response curve (Buchanan et al.,
2000; Haas, 2002; Zwietering and Havelaar, 2006), and these
assumptions have a major impact on the shape of the low end of
the curve.
The signiﬁcant obstacles to collecting robust data for rele-
vant and typically low doses will likely remain for some time.
Thus,thebeststrategyforreﬁningthedose-responseassessment
for foodborne pathogens is to advance the understanding of the
underlying biology, and by doing so, reﬁne the assumptions
that underlie predictive models. In particular, it is necessary to
improve the understanding of the sources of variability in dose-
response, and to quantify these various sources. The remainder
ofthispaperwilldiscusstheKeyEventsDose-ResponseFrame-
work, an analytical approach that is intended to shed light on
the critical factors that determine response to dose, including
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KEY EVENTS DOSE-RESPONSE FRAMEWORK:
POTENTIAL FOR USE WITH L. MONOCYTOGENES
Background
As described in the ﬁrst paper of this series (Julien et al.,
2009), the KEDRF involves the examination of the major bio-
logical steps that occur between the intake of a bioactive agent
and the onset of a speciﬁed adverse effect. At each step the
range of factors that may inﬂuence response are systemati-
cally examined, including dose (i.e., number of organisms),
pathogen factors (e.g., virulence), and protective host mecha-
nisms (e.g., immune response or other adaptive or homeostatic
mechanisms). It should be noted that, for pathogens, as opposed
to other types of agents considered in this ILSI RF project, the
interactions between the bioactive agent and the host can be
especially complex. As living organisms, pathogens have the
potential to develop highly dynamic interactions with hosts. For
example,pathogensoftenevolvesystemsthatcommandeerhost
resources, which are then used to help the pathogen survive and
grow.
Host characteristics (e.g., age, health status, etc.) are also
essential to consider. They may modify the effectiveness of the
homeostatic or immune response mechanisms of the host, or
otherwise contribute to the variability in response.
Theimpact of host and pathogen factorshas been recognized
for some time. The potential value of the KEDRF is in gaining
insight regarding how these factors inﬂuence dose-response,
i.e., how speciﬁc factors inﬂuence the probability of progres-
sion from one step to the next toward the ultimate effect of
concern, and how they may contribute to variability in the ul-
timate dose-response relationship. A deeper understanding of
these factors and their relative importance can be expected to
improve accuracy and reliability of the predictive models used
in public health. It will also help focus research on the types
of data needed to reduce reliance on the assumptions routinely
used when estimating risk from foodborne pathogenic bacte-
ria. Thus, the KEDRF approach complements, integrates, and
builds upon in vivo and in vitro approaches. The KEDRF helps
identify research questions that may be answered by those ex-
perimentalapproaches.Inturn,thedatatheygeneratewillreﬁne
the understanding of speciﬁc events in the KEDRF pathway.
As a means of illustrating the potential of this approach,
we consider how it might be applied to study dose-response
relationsforfetallisteriosisresultingfrommaternalingestionof
L. monocytogenes. After a brief overview of L. monocytogenes
and the pathogenesis of fetal listeriosis, this paper will discuss
individualKeyEventsandissuesthatcouldbeexaminedfurther
in a full Key Events Dose-Response Analysis.
L. monocytogenes is typically ingested via ready-to-eat
foods such as soft cheeses and deli meats (FDA/FSIS, 2003;
FAO/WHO, 2004). The pathogen is invasive; it crosses the in-
testinal epithelium and is transported to distal sites in the host
(e.g., spleen, liver, bone marrow, brain) (Swaminathan et al.,
2007). Illness is relatively rare, but is associated with a high fa-
tality rate. A 2003 FDA/FSIS risk assessment for L. monocyto-
genesestimatedthateachU.S.consumerhasan80%probability
each year of consuming a serving of food containing more than
1 million L. monocytogenes; however, only an estimated 2500
illnesses occur (Mead et al., 1999). These illnesses lead to about
500 deaths, resulting in a case fatality rate of about 20% (Mead
et al., 1999). Deaths can occur from septicemia or meningi-
tis in the elderly and immunocompromised individuals such
as transplant patients, chemotherapy patients, or AIDS pa-
tients(FDA/FSIS,2003;FAO/WHO,2004).Asigniﬁcantpublic
healthconcernistheingestionofcontaminatedfoodbypregnant
women. The listeriosis rate among pregnant women is similar
to other adults, but the fetus is 20 times more likely to develop
listeriosis compared to healthy individuals between the ages of
30 days and 60 years (FDA/FSIS, 2003; FAO/WHO, 2004).
Fetal listeriosis can potentially lead to spontaneous abortion,
stillbirths, or neonatal meningitis.
Overview of Pathogenesis for Fetal Listeriosis
The pathogenesis of L. monocytogenes for fetal listerio-
sis has been reviewed (Goldﬁne and Shen, 2007; Doyle and
Beuchat, 2007; Ryser and Marth, 2007) and is only brieﬂy sum-
marized here. Following the intake of a food product contain-
ing L. monocytogenes, the pathogen is exposed to the acidic
environment of the upper GI tract. Bacteria that survive that
environment enter the intestines where they may bind to ente-
rocytes, the epithelial cells that line the intestinal mucosa. The
binding and uptake into enterocytes is facilitated by interaction
of a protein (internalin A) on the bacterial surface with a host
receptor (E-cadherin) on the surface of the enterocytes. Once
taken into enterocytes by endocytosis, the bacteria escape from
the phagosomes and proliferate intracellularly (Gaillard et al.,
1987; Conte et al., 2000). The pathogen can then be transferred
to phagocytes, again escaping and proliferating (Conte et al.,
2000). Because of its ability to survive and multiply within
circulating phagocytic cells, L. monocytogenes can be dissemi-
nated throughout the body via blood and lymphatic circulation
into various tissues including liver, spleen, gall bladder, CNS
and, during pregnancy, the placenta and the fetus. Ultimately,
the pathogen is transferred from phagocytes to endothelial cells
attheultimatesiteoftheinfection(i.e.,thefetus)(Drevetsetal.,
1995).
An Initial Key Events Framework for Fetal Listeriosis
When applying the analytical approach of KEDRF, one of
the ﬁrst tasks is to describe the relevant pathway of Key Events.
The term “Key Event” has been deﬁned in the ﬁeld of chemical
risk assessment as an empirically observable precursor step that
is itself a necessary element of a chemical’s mode-of-action, or
a biologically based marker for such an element (Sonich-Mullin
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potentially useful analytical approach, we identiﬁed ﬁve major
and necessary steps as Key Events that lead to fetal listeriosis.
Future work on this subject will likely reﬁne this initial
description, and may describe additional, more speciﬁc steps
within the ﬁve discussed here. But, for purposes of this initial
study, the following ﬁve steps, i.e., the Key Events, will be dis-
cussed with regard to factors that may inﬂuence the probability
of progression from one step to the next, and also factors that
may contribute to the variability in the ultimate dose-response
relationship:
1. Survival of the pathogen in the upper GI tract
2. Establishment in the intestine; attachment to and uptake into
epithelial cells
3. Survival and escape from phagosomes in enterocytes, and
transfer of pathogen to phagocytes
4. Transfer of pathogen across placenta
5. Pathogen growth leading to fetal morbidity and mortality
It should be noted that the speciﬁc steps associated with
fetal listeriosis may differ from those leading to listeriosis in
othersusceptiblepopulations(e.g.,elderly,patientswithchronic
disease, transplant patients). Also, the steps discussed in this L.
monocytogenes example are likely to differ from steps for other
mechanistic categories (toxicoinfectious, toxigenic) and even
for other pathogens in the invasive category.
Figure 1 outlines the ﬁve Key Events that will be discussed.
Note that while each event between the initial intake and effect
of concern is part of a conditional chain of events, certain events
may also be considered “control points” in that they engage
host mechanisms that inﬂuence whether the cascade of events
progresses. That is, these control points engage mechanisms,
such as immune or homeostatic mechanisms, that serve to pro-
tect the normal environment. If these mechanisms fail (i.e.,
if control is lost), the pathogen has an opportunity to con-
tinue along the Key Events pathway toward the effect of
concern. Thus, at each event, there are several factors—dose
level, pathogen characteristics, and host mechanisms—that in
combination determine the probability (P) that progression
occurs.
Note that Fig. 1 could be used to represent events within a
given individual, or events within a given population. If Fig.
1 represents an individual, the outcome of each event can be
characterized by a binary yes or no (i.e., the outcome either
progresses toward the effect of concern, or it does not). If Fig. 1
refers to a population the probabilities of progression past each
event will reﬂect variability across the population.
KEY EVENTS PATHWAY:  L. monocytogenes intake and potential fetal death 
1-P P
Pathogens survive in upper GI tract
Establish; attach; taken up into epithelial cells 
Escape from phagosomes; transfer to phagocytes
Transfer across placenta 
Grow; results in fetal mortality
Do not survive 
Do not establish, etc. 
Do not escape 
Do not transfer 
Do not grow 
INTAKE OF CONTAMINATED FOOD 
P 1-P
P 1-P
P 1-P
P 1-P
Interplay of host 
and pathogen 
can influence 
progression at 
various events 
Figure 1 Key biological events occurring between intake of pathogen and the speciﬁc effect of concern (fetal listeriosis). At each event, both host and pathogen
factors can be examined with regard to: i) how they may inﬂuence probability of progression toward the effect of concern (i.e., how they affect the number of
organisms exiting a given event, given the number of organisms entering the event), and ii) how they inﬂuence inter- and intra- host response variability.KEDRF AND ITS POTENTIAL FOR FOODBORNE PATHOGENIC MICROORGANISMS 723
Observations Regarding Key Events for Fetal Listeriosis
Key Event 1: Survival of the Pathogen in the Upper GI Tract
Several factors affect how many, if any, L. monocytogenes
survive the acidic environment of the upper GI tract, including
the food matrix, the quantity and composition/acidity of foods
consumed,andthegenerallevelofacidityintheGItract.Certain
host characteristics or behaviors (e.g., antacids consumption,
achlorhydria) may reduce acid production and thus increase the
probability of pathogen survival. Pathogen adaptability can also
affect the outcome of this event. L. monocytogenes is known
to have mechanisms that increase acid resistance, and these
mechanisms are induced by prior exposure to moderately acid
conditions (Kroll and Patchett, 1992; Buchanan et al., 1994;
Wiedmannetal.,1998;Formatoetal.,2007;Adriaoetal.,2008;
Ryan et al., 2009). These adaptive mechanisms have also been
associated with increased expression of virulence determinants
(O’Driscoll et al., 1996; Cotter et al., 1999; Gahan et al., 1999;
Hill et al., 2000). Despite the various host and pathogen factors
that are available to inﬂuence L. monocytogenes survival, the
numbers that survive the GI tract are generally assumed to be
proportional to the numbers ingested, and the dose response
curves in animal models support this assumption (Williams
et al., 2007; Smith et al., 2008).
Key Event 2: Establishment in the Intestine, Attachment to and
Uptake into Epithelial Cells
Littleisknownregardingspeciﬁcpathogenfactorsthatinﬂu-
encetheextentoftheL.monocytogenes’growthintheintestinal
lumen or after it has attached to the intestinal mucosa. But the
growth of the microorganism in the lumen would be expected
to increase the probability that the bacteria ﬁnd and bind to re-
ceptor sites on the intestinal epithelium. Similarly, growth on
the surface of the enterocyte would be expected to increase the
number of L. monocytogenes cells internalized. Host factors
that affect the local GI response are not well characterized in
quantitative terms, but the host innate immune response (i.e.,
proinﬂammatory cytokines macrophages, monocytes, polymor-
phonuclear leukocytes, and natural killer cells) will reduce the
numbers of microbes that colonize the intestine.
L. monocytogenes are taken into enterocytes via receptor
mediated endocytosis. Host E-cadherin receptors bind with in-
ternalin (InlA), a bacterial surface protein that is controlled by
the prfA regulatory gene. Differences in InlA are believed to
be one of the factors that differ in the three genetic lineages
recognized for L. monocytogenes (Jia et al., 2007). Factors
potentially affecting the probability of uptake via endocytosis
into enterocytes include strain differences, growth stage, prior
growth conditions, induction of bacterial stress response, and
various host differences such as age or immune status (Dramsi
et al., 1993; Domann et al., 1997; Lecuit et al., 1997, 2001;
McGann et al., 2007a, 2007b; Linden et al., 2008; Milillo et al.,
2009).
Key Event 3: Survival and Escape from Phagosomes and
Transfer to Phagocytes
Once taken up into the enterocyte by endocytosis, pathogens
would generally be subject to degradation in phagosome vac-
uoles. However, most L. monocytogenes strains have the ability
to survive, and ultimately escape, from phagosomes due to their
ability to synthesize listeriolysin O (LLO) (Gaillard et al., 1987;
Del Corral et al., 1990; Lam and Brumell, 2008). In response
to acidiﬁcation of the phagosome, LLO undergoes structural re-
conﬁguration that renders the protein stable and active. It then
forms small pores in the phagosome, blocking the acidiﬁcation
ofthiscompartmentandtherebypreventingitsfusionwithlyso-
somes(Singhetal.,2008).Thisprovidesa“windowofopportu-
nity”forL.monocytogenestoescapethephagosomeandinitiate
growth in the cytoplasm, and involves the combined actions of
LLO and two phospholipase enzymes (Mengaud et al., 1991;
Camillietal.,1991;Notermansetal.,1991;Marquisetal.,1995,
2000; Smith et al., 1995; Goldﬁne et al., 1998; Das et al., 2001;
Wei et al., 2005). LLO activity is promoted by γ -interferon
inducible lysosomal thiol reductase (GILT) in the host, and is
further augmented by the induction of an acid tolerance system
within L. monocytogenes (Conte et al., 2000). GILT appears to
beacriticalhostfactor,andmicethatlackGILTareresistanttoL.
monocytogenesinfection(Singhetal.,2008).Oncereleasedinto
the cytoplasm, the actively growing pathogen can spread from
cell to cell via ActA polymerization of the host cell actin, which
supports movement within the cytoplasm to the membrane-
membrane interface with adjacent cells. The bacteria are then
spread to other enterocytes and ultimately to phagocytes, which
disseminate the pathogen through the maternal circulatory and
lymph system to various organs including the placenta.
Two attributes that are central to the ability of L. monocy-
togenes to cause disease are its ability to synthesize LLO and
thus escape from the phagosomes, and its ability to transfer
among enterocytes, phagocytes, and endothelial cells while
remaining in an intracellular environment. This movement of
L. monocytogenes in cells via phagocytosis/endocytosis evades
the humoral immune system (Tilney and Portnoy, 1989; Del
Corral et al., 1990; Dabiri et al., 1990; Mounier, et al., 1990;
Kocks et al., 1992; Sanger et al., 1992; Tilney et al., 1992;
Pistor et al., 1994; Grenklo et al., 2003). Listeriolysin synthesis
is a distinguishing characteristic of L. monocytogenes.I fa
strain does not have a functional listeriolysin gene or cannot
synthesize LLO, it will not escape the phagosome. The extent
of LLO production varies among L. monocytogenes strains
(Parrisius et al., 1986; Datta and Kothary, 1993) and may be a
determinant in their relative virulence.
Key Event 4: Transfer of Pathogen across Placenta
The speciﬁc mechanism by which L. monocytogenes crosses
the placenta is under study, and two different mechanisms have
been hypothesized—the invasion of the endothelial cells via
InlA-E-cadherin interaction (Lecuit et al., 1999, 2004), and
actin-mediated cell-to-cell transfer from infected phagocytes724 R. L. BUCHANAN ET AL.
to placental endothelial cells (Drevets et al., 1995). Cells
with E-cadherin receptors (e.g., liver cells, intracerebral mi-
crovascular endothelial cells, chorionic villi of the placenta)
are the sites associated with invasive listeriosis (Lecuit et al.,
1999). This suggests a direct interaction between bloodborne
L. monocytogenes cells and the placental endothelial cells
(Lecuit et al., 2004). Other investigations suggest that transfer
across the placenta involves stimulation of polymorphonuclear
leukocytes adhesion and cell-to-cell transfer (Drevets, 1998).
This hypothesis is reinforced by evidence of a decreased ability
of the pathogen to invade placental tissue in ActA− mutants
(Le Monnier et al., 2007), and also by the lack of a maternal
humoral immune response prior to stillbirth in studies using
rhesus monkeys (Smith et al., 2003). In these studies, L. mono-
cytogenes could not be isolated from the serum, nor was there
any increase in antisera titers at 4 days or 14 days after oral ex-
posure to L. monocytogenes. There was a signiﬁcant increase in
antisera titers at the time of stillbirth, however, which occurred
concurrently with tissue breakdown in the placenta and fetus.
The difference in these proposed mechanisms has implica-
tions with regard to the host’s ability to prevent progression to-
ward fetal listeriosis. A mechanism that utilizes actin-mediated
cell-to-cell transmission would protect the pathogen from
the humoral immune response, whereas a receptor-mediated
bacterial-endothelial interaction would offer the possibility of
humoral immune protection if the maternal immune system can
respond rapidly enough.
Key Event 5: Pathogen Growth Leading to Fetal Morbidity and
Mortality
IfL.monocytogenessuccessfullytransferacrosstheplacenta,
they gain entry to fetal circulation and may spread cell-to-cell
ultimately colonizing the fetal liver and brain (Bakardjiev et al.,
2005; Williams et al., 2007; Jensen et al., 2008). Fetuses lack
a fully competent immune system, and thus are at great risk
of infection if the pathogen crosses the placenta. While fetal
colonization results in an asymptomatic maternal infection, it
may also result in spontaneous abortion, delivery of a stillborn
infant, or delivery of an infant infected with L. monocytogenes.
The outcome may be affected by the timing of the infection
(early or late in the gestational period). The details of mater-
nal and placental immunity (Irvin et al., 2008a; Irvin et al.,
2008b) are not fully known but specialized immune functions
during pregnancy and in the placenta may be associated with
Th1 cytokines (Barber et al., 2005) and changes in the Th1/Th2
cytokine ratios (Lin et al., 2003). It is not known whether death
ofthefetusoccursbyreactionofthematernalsystemtofetalin-
fection, loss of placental integrity, infection of the fetus directly,
or some combination of these processes.
DISCUSSION
This brief overview of Key Events in the L. monocytogenes
pathway illustrates how a systematic analytical approach would
help to “tease out” the complex factors that determine response
to a given initial dose. A more in–depth analysis of current
knowledge at individual events should be conducted, and would
be a basis for generating speciﬁc hypotheses and for identifying
researchpriorities.Eventhisinitialexaminationgeneratedsome
new insights.
For example, this analysis highlighted some potential dif-
ferences across the various Key Events. Several events do not
appear to engage to any signiﬁcant extent, speciﬁc host mech-
anisms in response to the pathogen (e.g., survival through the
upper intestinal tract, attachment to the intestinal epithelium).
Thus, the outcomes of these Key Events appear to be funda-
mentally probabilistic in nature. As such, the dose-response
relationship for the individual event would most appropriately
be described as nonthresholded or log-linear. Other Key Events
inthepathway,however,engagemorespeciﬁchostmechanisms
that work to preserve homeostasis and prevent progression to-
ward fetal listeriosis. But these host mechanisms may have a
ﬁnite capacity that can be overcome with “high enough” num-
bers of pathogens. At such a point, an increase in pathogen
dose would not simply increase the probability of progression;
rather, more complex (predator-prey) interactions would need
to be considered. If host mechanisms have been exhausted, an
increase in pathogen dose might ensure progression along the
pathway. This possibility that certain Key Events might be best
characterized by a linear dose-response curve and others by a
nonlinear curve could be examined in a comprehensive analysis
of Key Events for L. monocytogenes.
The above discussion of Key Events also noted some places
where speciﬁc host attributes might explain some of the overall
variability in dose-response. Clearly, certain host attributes,
in particular deﬁciencies in the immune response, underlie
and deﬁne the susceptible population for many pathogens.
But even within susceptible populations, the attack rate for
some pathogens, such as L. monocytogenes, is low (FDA/FSIS,
2003). Thus, other host factors (i.e., genetic differences,
exposure patterns, etc.) likely contribute. Again, a full analysis
of individual Key Events would likely generate hypotheses
regarding the contribution of speciﬁc host factors to overall
variability. Once identiﬁed and quantiﬁed, these factors could
be used to more precisely characterize susceptible individuals
within a susceptible population.
Similarly, pathogen variability at particular Key Events may
be equally important in determining whether a given infection
results in illness. Various genetic lineages and polymorphisms
associated with determinants of virulence result in substantial
strain-to-strain variability, affecting how quickly the pathogen
cangrowandovercomethebarriersandresponseofthehost.The
stress responses of a pathogen (e.g., pH tolerance, resistance to
oxidative stress) may also affect the dose-response curve, shift-
ing the curve left along the x-axis. Also, quorum sensing pro-
cesses may become engaged and regulate genes that inﬂuence
the virulence of a pathogen (e.g., toxins, proteases, hemolysins,
adhesins), and stress responses, thereby affecting the outcome
of later key events (Anand and Grifﬁths, 2003; Joelsson et al.,KEDRF AND ITS POTENTIAL FOR FOODBORNE PATHOGENIC MICROORGANISMS 725
2007). These multiple sources of variability are already known,
but the Key Events approach helps to pinpoint the speciﬁc steps
in the overall pathway where these pathogen factors may exert
their inﬂuence and where a more comprehensive examination
would be especially fruitful.
An example of a pathogen attribute that strongly affects the
ultimate outcome in the fetal listeriosis pathway is the ability of
L. monocytogenes to escape from the phagosome. This ability
to escape requires the production of sufﬁcient LLO and phos-
pholipases before the pathogen becomes inactivated. Thus, high
numbersofL.monocytogenesinphagosomes,orthepresenceof
strains that produce elevated levels of LLO, would seem more
likely to lead to fetal listeriosis. As noted previously, this at-
tribute varies across strains and may contribute to differences
in virulence. Likewise, the ability to spread among enterocytes,
phagocytes, and endothelial cells (via actin mediated transfer)
while remaining in an intracellular environment is an essen-
tial attribute if infection is to lead to fetal listeriosis. It may be
useful to examine whether variability in this particular attribute
contributes to overall variability in virulence.
CONCLUSION
Current approaches to dose-response assessment for low-
dose exposures to microorganisms in foods rely on multiple
assumptions and extrapolations to cope with limitations in
knowledge and also limitations in our ability to effectively
measure variability (e.g., variability among humans, strain dif-
ferences among pathogens). The KEDRF offers an analytical
framework for better utilizing current and future data to gain in-
sight regarding dose-response based on understanding the crit-
ical biological events that occur between exposure and disease.
The present study provides an initial example of the potential of
this approach for evaluating pathogenic microorganisms.
The initial Key Events analysis developed for fetal listeriosis
provided a structure for systematically considering the complex
array of host and pathogen factors that inﬂuence dose-response.
These factors were considered at the level of individual Key
Events, where they interact; but they could also be further con-
sidered in the context of the overall pathway of events. The
present exercise also highlighted some key research needs. Fu-
ture work should reﬁne the description of the pathway and con-
duct a more comprehensive analysis of currently available data.
Itwillbeespeciallyusefultoexamineinformationonhosthome-
ostatic mechanisms, and the conditions under which they may
reach their capacity. In summary, the use of this approach can
be expected to generate new hypotheses and focused research,
which will provide new data and subsequently reﬁne the un-
derstanding of the overall pathway. Thus, the KEDRF approach
provides a basis for continuous iterative improvement in micro-
bial dose-response assessment.
Note that the KEDRF, in combination with data on inter-
actions at speciﬁc events, should be particularly helpful for
informing the development of predictive models. The frame-
work provides a connection between dose-response relations
as measured at individual events and the dose-response rela-
tionship that is ultimately of concern. Data and knowledge for
speciﬁc Key Events will provide more direct evidence to in-
form and reﬁne assumptions that underlie dose-response mod-
els. Also, the framework helps connect data on variability at
individual Key Events to the variability observed at the pop-
ulation level. These connections will lead to more informed
dose-response characterizations for foodborne pathogenic bac-
teria and ultimately strengthen the scientiﬁc basis of food safety
regulation. A clear understanding of the underlying biology
is critical to making scientiﬁcally-based, risk-based decisions
about the level of control needed in order to meet public health
goals (CAC, 2007).
The type of analysis described above for L. monocytogenes
could be applied to other foodborne pathogens as well, each
of which has key events associated with the expression of spe-
ciﬁc virulence factors. For example, a substantial portion of
Escherichia coli strains have the ability to produce shiga toxin;
however, only a small percentage of the strains are associated
with hemorrhagic colitis and hemolytic uremic syndrome, for
example, E. coli O157:H7. The likely key events associated
with enterohemorrhagic strains are survival through the upper
gastrointestinal tract, attachment to the intestinal epithelium,
the colonization of the attachment site, the production of shiga-
toxin, and the dissemination of the toxin throughout the body.
In this instance, eae gene-mediated attachment to enterocytes
may be the critical attribute that could be used to effectively
differentiate enterohemorrhagic E. coli from other shiga toxin-
producing strains. In turn, such knowledge could be used to
establish appropriate biologically based regulatory criteria for
the various classes of potentially pathogenic E. coli strains.
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APPENDIX
Table A-1 Overview of Mechanistic Catagories for Pathogenic Bacteria
Toxigenic bacteria: Produce preformed toxins in foods
Staphylococcus aureus produces a highly heat stable enterotoxin. This bacterium is traditionally associated with products that have been temperature abused
sufﬁciently to allow S. aureus to attain high levels and produce its enterotoxins. Even if food is subsequently cooked, the extreme heat stability of the
enterotoxin would result in illness.
Clostridium botulinum neurotoxin (BoTN) is produced during the growth of C. botulinum – an obligate anaerobe and spore former – in canned foods, various
fermented, dried or salted meat and ﬁsh that are not properly produced and/or refrigerated, and various other foods where the oxygen content is limited. The
toxin appears to be associated with the outer bacterial cell coat and is sloughed off into the food product as the culture grows.
Toxicoinfectious bacteria: Colonize surface of the GI tract
One subgroup (e.g., Vibrio cholerae and enterotoxigenic Escherichia coli (ETEC)) delivers toxin directly into epithelial cells to which the bacterium has attached.
Once inside the epithelial cell, the enterotoxins typically affect cyclic AMP- or cyclic GMP-mediated net Cl– secretion, often resulting in severe diarrhea.
A second subgroup (e.g., enterohemorrhagic E. coli [EHEC]), colonize the surface of endothelial cells and elicit toxin (Shiga toxin (Stx)), which locally disrupts
the integrity of the intestinal tract, most likely as a means of acquiring limiting nutrients such as iron. Focal necrosis of epithelial cells leads to the primary
adverse effect - hemorrhagic colitis (HC). Stx is also taken up by the host and transported to distant internal tissue where it can lead to primary sequelae -
hemolytic uremic syndrome (HUS).
A third subgroup (e.g., Clostridium perfringens) produces an enterotoxin associated with sporulation. Microorganism typically sporulates poorly in foods so high
levels of enterotoxin are not observed. When microorganisms are ingested, cells sporulate in the intestinal tract, undergo autolysis, and enterotoxin is released
into the lumen.
Invasive bacteria: Invade across intestinal epithelium and disseminate within the host
One subgroup (e.g., Salmonella enterica, Shigella spp. and enteroinvasive E. coli) invades the epithelium, spreads intercellularly, and causes focal
microulcerations of the mucosa.
A second subgroup (e.g., Yersinia enterocolitica and Yersinia pseudotuberculosis) crosses the epithelium and proceeds to regional lymph nodes, causing severe
abdominal pain and, occasionally, mesenteric lymphadenitis. Campylobacter jejuni may also translocate across the mucosa and survive submucosally, but does
not typically reach the bloodstream.
A third subgroup (e.g., Salmonella Typhi and Paratyphi, Listeria monocytogenes) translocates across the epithelium, and may then be transported to distal sites in
the host (e.g., spleen, liver, and bone marrow, brain).